Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myoclonic Epilepsy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00368251
What this trial is testing

Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and Adults

Who this might be right for
Unverricht-Lundborg Disease
UCB Pharma 56
Very early researchLooking for participantsNCT07675746
What this trial is testing

Evaluate the Safety and Pharmacokinetics of RC001 in Children With Dravet Syndrome

Who this might be right for
Dravet Syndrome (DS)
Second Affiliated Hospital of Guangzhou Medical University 8
Not applicableStudy completedNCT05544058
What this trial is testing

Retrospective Non-interventional Study of Stiripentol Use in Dravet Patients in the USA

Who this might be right for
Dravet Syndrome
Biocodex 100
Not applicableActive Not RecruitingNCT05373719
What this trial is testing

Observational Study in Patients With Cyclin-dependent Kinase-like 5 Deficiency Disorder

Who this might be right for
Cyclin-Dependent Kinase-Like 5 Deficiency Disorder
Loulou Foundation 112
Testing effectiveness (Phase 2)Study completedNCT01607073
What this trial is testing

Verapamil as Therapy for Children and Young Adults With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Gillette Children's Specialty Healthcare 2
Testing effectiveness (Phase 2)UnknownNCT00639119
What this trial is testing

Effect of Ropinirole Hydrochloride in Progressive Myoclonic Epilepsy of Unverricht-Lundborg Type

Who this might be right for
Unverricht-Lundborg Syndrome
University of Turku 16
Large-scale testing (Phase 3)Study completedNCT00357669
What this trial is testing

Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults

Who this might be right for
Unverricht-Lundborg Disease
UCB Pharma SA 50
Testing effectiveness (Phase 2)Study completedNCT04442295
What this trial is testing

An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Stoke Therapeutics, Inc 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT06283212
What this trial is testing

A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Children With SCN1A-positive Dravet Syndrome

Who this might be right for
Dravet Syndrome
Encoded Therapeutics 5
Testing effectiveness (Phase 2)Study completedNCT05626634
What this trial is testing

Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy

Who this might be right for
Developmental and Epileptic EncephalopathyDravet SyndromeLennox-Gastaut Syndrome
Longboard Pharmaceuticals 41
Post-approval studies (Phase 4)Looking for participantsNCT07112365
What this trial is testing

The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project

Who this might be right for
Dravet Syndrome
The University of Texas Health Science Center, Houston 25
Not applicableLooking for participantsNCT07013331
What this trial is testing

A PET-MRI Study of Serotoninergic Brainstem Pathway in Patients With Dravet Syndrome

Who this might be right for
EpilepsyDravet SyndromeDrug Resistant Epilepsy+1 more
Hospices Civils de Lyon 30
Large-scale testing (Phase 3)Study completedNCT02318602
What this trial is testing

Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder

Who this might be right for
Seizures
INSYS Therapeutics Inc 52
Not applicableLooking for participantsNCT07251673
What this trial is testing

Longitudinal Study of Phenotypic and Developmental Severity in Patients With Dravet Syndrome With SCN1A Gene Mutation

Who this might be right for
Dravet Syndrome
Assistance Publique - Hôpitaux de Paris 50
Testing effectiveness (Phase 2)Ended earlyNCT06153186
What this trial is testing

Flunarizine for Treatment Resistant Absence Epilepsy

Who this might be right for
Childhood Absence EpilepsyJuvenile Absence EpilepsyJuvenile Myoclonic Epilepsy
University of British Columbia 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT07084311
What this trial is testing

Personalized Antisense Oligonucleotide for A Single Participant With ATN1 Gene Mutation

Who this might be right for
Dentatorubral-Pallidoluysian Atrophy
n-Lorem Foundation 1
Not applicableUnknownNCT06273150
What this trial is testing

Dentatorubral-pallidoluysian Atrophy Natural History and Biomarkers Study

Who this might be right for
Dentatorubral-Pallidoluysian Atrophy
University College, London 225
Large-scale testing (Phase 3)Not Yet RecruitingNCT07723963
What this trial is testing

Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy

Who this might be right for
Juvenile Myoclonic Epilepsy
Jazz Pharmaceuticals 260
Large-scale testing (Phase 3)Study completedNCT00150774
What this trial is testing

Levetiracetam as add-on Treatment of Myoclonic Jerks in Adolescents + Adults

Who this might be right for
Generalized Convulsive Epilepsy
UCB Pharma 116
Testing effectiveness (Phase 2)Looking for participantsNCT05419492
What this trial is testing

A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome

Who this might be right for
Dravet Syndrome
Encoded Therapeutics 47
Next Page